{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:46:41Z","timestamp":1790876801896,"version":"4.1.0"},"reference-count":205,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T00:00:00Z","timestamp":1666396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007046","name":"Wuhan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31972936"],"award-info":[{"award-number":["31972936"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Insight"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.cellin.2022.100067","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T13:28:53Z","timestamp":1666790933000},"page":"100067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Current advances of CRISPR-Cas technology in cell therapy"],"prefix":"10.1016","volume":"1","author":[{"given":"Hou-Yuan","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Jin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4044-0230","authenticated-orcid":false,"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellin.2022.100067_bib2","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1182\/blood.V80.6.1586.1586","article-title":"Developmental switching of messenger RNA expression from the human alpha-globin cluster: fetal\/adult pattern of theta-globin gene expression","volume":"80","author":"Albitar","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.cellin.2022.100067_bib3","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood-2010-09-309591","article-title":"Evidence for the cure of HIV infection by CCR5Delta32\/Delta32 stem cell transplantation","volume":"117","author":"Allers","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cellin.2022.100067_bib4","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1158\/0008-5472.CAN-20-2990","article-title":"Macrophage-based approaches for cancer immunotherapy","volume":"81","author":"Anderson","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellin.2022.100067_bib5","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41587-021-01133-w","article-title":"Programmable deletion, replacement, integration and inversion of large DNA sequences with twin prime editing","volume":"40","author":"Anzalone","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cellin.2022.100067_bib6","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cellin.2022.100067_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2022.100067_bib8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1200\/JCO.2015.63.3826","article-title":"Allogeneic hematopoietic cell transplantation for acute myeloid leukemia: time to move toward a minimal residual disease-based definition of complete remission?","volume":"34","author":"Araki","year":"2016","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.cellin.2022.100067_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.cellin.2022.100067_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioelechem.2021.107871","article-title":"Cell death due to electroporation - a review","volume":"141","author":"Batista Napotnik","year":"2021","journal-title":"Bioelectrochemistry"},{"key":"10.1016\/j.cellin.2022.100067_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1586\/1744666X.2014.865519","article-title":"Cellular and molecular mechanisms in cancer immune escape: a comprehensive review","volume":"10","author":"Bhatia","year":"2014","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.cellin.2022.100067_bib12","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1021\/acs.nanolett.9b04246","article-title":"Ionizable lipid nanoparticle-mediated mRNA delivery for human CAR T cell engineering","volume":"20","author":"Billingsley","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.cellin.2022.100067_bib92","author":"Bioray Laboratories"},{"key":"10.1016\/j.cellin.2022.100067_bib14","doi-asserted-by":"crossref","first-page":"11978","DOI":"10.1073\/pnas.1819992116","article-title":"Gene-edited stem cells enable CD33-directed immune therapy for myeloid malignancies","volume":"116","author":"Borot","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cellin.2022.100067_bib15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41586-022-04470-1","article-title":"Structural basis for mismatch surveillance by CRISPR-Cas9","volume":"603","author":"Bravo","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2022.100067_bib16","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1128\/MCB.23.12.4199-4206.2003","article-title":"CD33\/Siglec-3 binding specificity, expression pattern, and consequences of gene deletion in mice","volume":"23","author":"Brinkman-Van der Linden","year":"2003","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.cellin.2022.100067_bib17","first-page":"1490","article-title":"Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia","volume":"7","author":"Bross","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellin.2022.100067_bib18","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1182\/blood.V77.7.1546.1546","article-title":"Stages of T-cell receptor protein expression in T-cell acute lymphoblastic leukemia","volume":"77","author":"Campana","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.cellin.2022.100067_bib19","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.blre.2018.02.001","article-title":"A\u00a0paradigm shift on beta-thalassaemia treatment: how will we manage this old disease with new therapies?","volume":"32","author":"Cappellini","year":"2018","journal-title":"Blood Rev."},{"key":"10.1016\/j.cellin.2022.100067_bib20","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/S0140-6736(12)60485-1","article-title":"Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study","volume":"379","author":"Castaigne","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.cellin.2022.100067_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aap9630","article-title":"Hematopoietic stem cell transplantation in its 60s: a platform for cellular therapies","volume":"10","author":"Chabannon","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cellin.2022.100067_bib214","author":"Chen"},{"key":"10.1016\/j.cellin.2022.100067_bib22","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.1016\/j.cell.2021.09.018","article-title":"Enhanced prime editing systems by manipulating cellular determinants of editing outcomes","volume":"184","author":"Chen","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.cellin.2022.100067_bib23","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.addr.2020.10.014","article-title":"Recent advances in chemical modifications of guide RNA, mRNA and donor template for CRISPR-mediated genome editing","volume":"168","author":"Chen","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.cellin.2022.100067_bib218","author":"Chen"},{"key":"10.1016\/j.cellin.2022.100067_bib24","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrd4506","article-title":"Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens","volume":"14","author":"Childs","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cellin.2022.100067_bib158","author":"Zhou"},{"issue":"9","key":"10.1016\/j.cellin.2022.100067_bib209","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/s41587-022-01254-w","article-title":"An engineered prime editor with enhanced editing efficiency in plants","volume":"40","author":"Zong","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cellin.2022.100067_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz5618","article-title":"iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti-PD-1 therapy","volume":"12","author":"Cichocki","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cellin.2022.100067_bib27","article-title":"High-affinity CD16 integration into a CRISPR\/Cas9-edited CD38 locus augments CD38-directed antitumor activity of primary human natural killer cells","volume":"10","author":"Clara","year":"2022","journal-title":"J\u00a0Immunother Cancer"},{"key":"10.1016\/j.cellin.2022.100067_bib28","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41467-020-20633-y","article-title":"CRISPR technologies and the search for the PAM-free nuclease","volume":"12","author":"Collias","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellin.2022.100067_bib210","author":"CRISPR Therapeutics"},{"key":"10.1016\/j.cellin.2022.100067_bib29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nri2056","article-title":"Siglecs and their roles in the immune system","volume":"7","author":"Crocker","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellin.2022.100067_bib30","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2019-130256","article-title":"EDIT-301: an experimental autologous cell therapy comprising cas12a-RNP modified mPB-CD34+Cells for the potential treatment of SCD","volume":"134","author":"De Dreuzy","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.cellin.2022.100067_bib31","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1038\/bcj.2016.50","article-title":"Acute myeloid leukemia: a comprehensive review and 2016 update","volume":"6","author":"De Kouchkovsky","year":"2016","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.cellin.2022.100067_bib32","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah3480","article-title":"CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease","volume":"9","author":"De Ravin","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cellin.2022.100067_bib33","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/381661a0","article-title":"Identification of a major co-receptor for primary isolates of HIV-1","volume":"381","author":"Deng","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2022.100067_bib34","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1126\/science.1158799","article-title":"Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons","volume":"321","author":"Dimos","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.cellin.2022.100067_bib37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature21405","article-title":"Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection","volume":"543","author":"Eyquem","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2022.100067_bib38","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/s41587-020-0551-y","article-title":"Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking","volume":"38","author":"Ferrari","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cellin.2022.100067_bib39","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41591-018-0010-1","article-title":"Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia","volume":"24","author":"Fraietta","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellin.2022.100067_bib40","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and beta-thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cellin.2022.100067_bib41","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1038\/s41591-022-01906-z","article-title":"CRISPR-Cas9-mediated gene editing of the BCL11A enhancer for pediatric beta(0)\/beta(0) transfusion-dependent beta-thalassemia","volume":"28","author":"Fu","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellin.2022.100067_bib42","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.cell.2017.09.039","article-title":"The DNA inflammasome in human myeloid cells is initiated by a STING-cell death program upstream of NLRP3","volume":"171","author":"Gaidt","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cellin.2022.100067_bib43","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1089\/crispr.2021.0080","article-title":"Genomic and transcriptomic analyses of prime editing guide RNA-independent off-target effects by prime editors","volume":"5","author":"Gao","year":"2022","journal-title":"CRISPR J"},{"key":"10.1016\/j.cellin.2022.100067_bib44","doi-asserted-by":"crossref","first-page":"E2579","DOI":"10.1073\/pnas.1208507109","article-title":"Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria","volume":"109","author":"Gasiunas","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cellin.2022.100067_bib45","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A\u2217T to G\u2217C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2022.100067_bib46","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/s41587-020-0491-6","article-title":"Directed evolution of adenine base editors with increased activity and therapeutic application","volume":"38","author":"Gaudelli","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cellin.2022.100067_bib47","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nbt.4199","article-title":"An APOBEC3A-Cas9 base editor with minimized bystander and off-target activities","volume":"36","author":"Gehrke","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cellin.2022.100067_bib48","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1039\/C3LC50566A","article-title":"Microfluidic electroporation for cellular analysis and delivery","volume":"13","author":"Geng","year":"2013","journal-title":"Lab Chip"},{"key":"10.1016\/j.cellin.2022.100067_bib49","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1182\/blood-2013-09-529537","article-title":"Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells","volume":"123","author":"Gill","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.cellin.2022.100067_bib50","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature22976","article-title":"Identifying specificity groups in the T cell receptor repertoire","volume":"547","author":"Glanville","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2022.100067_bib51","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.tibtech.2017.11.006","article-title":"Engineering the delivery system for CRISPR-based genome editing","volume":"36","author":"Glass","year":"2018","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.cellin.2022.100067_bib52","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1182\/blood-2017-01-761320","article-title":"CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies","volume":"130","author":"Gomes-Silva","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.cellin.2022.100067_bib212","author":"Great Ormond Street Hospital for Children NHS Foundation Trust"},{"key":"10.1016\/j.cellin.2022.100067_bib54","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s41587-020-0535-y","article-title":"A\u00a0dual-deaminase CRISPR base editor enables concurrent adenine and cytosine editing","volume":"38","author":"Grunewald","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cellin.2022.100067_bib55","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41591-018-0049-z","article-title":"CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response","volume":"24","author":"Haapaniemi","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellin.2022.100067_bib56","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1126\/science.1245813","article-title":"Genetics. GWAS to therapy by genome edits?","volume":"342","author":"Hardison","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.cellin.2022.100067_bib57","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nbt.3290","article-title":"Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells","volume":"33","author":"Hendel","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cellin.2022.100067_bib58","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1146\/annurev-genet-051710-150955","article-title":"Regulation of homologous recombination in eukaryotes","volume":"44","author":"Heyer","year":"2010","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.cellin.2022.100067_bib59","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/mt.2016.148","article-title":"CRISPR\/Cas9-Mediated correction of the sickle mutation in human CD34+ cells","volume":"24","author":"Hoban","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cellin.2022.100067_bib61","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41591-018-0050-6","article-title":"p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells","volume":"24","author":"Ihry","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellin.2022.100067_bib69","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1261\/rna.5430403","article-title":"Novel \"anti-reverse\" cap analogs with superior translational properties","volume":"9","author":"Jemielity","year":"2003","journal-title":"RNA"},{"key":"10.1016\/j.cellin.2022.100067_bib70","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1158\/1078-0432.CCR-17-3179","article-title":"FDA approval: gemtuzumab ozogamicin for the treatment of adults with newly diagnosed CD33-positive acute myeloid leukemia","volume":"24","author":"Jen","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellin.2022.100067_bib71","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1038\/s41467-018-05245-x","article-title":"Direct observation of DNA target searching and cleavage by CRISPR-Cas12a","volume":"9","author":"Jeon","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellin.2022.100067_bib72","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.molcel.2020.07.005","article-title":"Rationally designed APOBEC3B cytosine base editors with improved specificity","volume":"79","author":"Jin","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cellin.2022.100067_bib73","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1038\/s41587-021-00891-x","article-title":"Genome-wide specificity of prime editors in plants","volume":"39","author":"Jin","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cellin.2022.100067_bib74","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A\u00a0programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.cellin.2022.100067_bib75","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.aar6711","article-title":"CAR T cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.cellin.2022.100067_bib76","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1093\/nar\/gkr695","article-title":"Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA","volume":"39","author":"Kariko","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cellin.2022.100067_bib77","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability","volume":"16","author":"Kariko","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cellin.2022.100067_bib78","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nbt940","article-title":"Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase","volume":"22","author":"Kim","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cellin.2022.100067_bib79","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nmeth.4104","article-title":"In vivo high-throughput profiling of CRISPR-Cpf1 activity","volume":"14","author":"Kim","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cellin.2022.100067_bib80","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.cell.2018.05.013","article-title":"Genetic inactivation of CD33 in hematopoietic stem cells to enable CAR T cell immunotherapy for acute myeloid leukemia","volume":"173","author":"Kim","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.cellin.2022.100067_bib81","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1101\/gr.171322.113","article-title":"Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins","volume":"24","author":"Kim","year":"2014","journal-title":"Genome Res."},{"issue":"3","key":"10.1016\/j.cellin.2022.100067_bib82","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1101\/gr.231936.117","article-title":"CRISPR RNAs trigger innate immune responses in human cells","volume":"28","author":"Kim","year":"2018","journal-title":"Genome Res."},{"key":"10.1016\/j.cellin.2022.100067_bib83","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature14592","article-title":"Engineered CRISPR-Cas9 nucleases with altered PAM specificities","volume":"523","author":"Kleinstiver","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2022.100067_bib84","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ymthe.2021.10.026","article-title":"Disruption of HIV-1 co-receptors CCR5 and CXCR4 in primary human T cells and hematopoietic stem and progenitor cells using base editing","volume":"30","author":"Knipping","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cellin.2022.100067_bib85","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nbt.4172","article-title":"Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction","volume":"36","author":"Koblan","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cellin.2022.100067_bib86","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0092-8674(87)90504-6","article-title":"Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals","volume":"50","author":"Koenig","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.cellin.2022.100067_bib87","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2022.100067_bib88","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aao4774","article-title":"Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C:G-to-T:A base editors with higher efficiency and product purity","volume":"3","author":"Komor","year":"2017","journal-title":"Sci. Adv."},{"key":"10.1016\/j.cellin.2022.100067_bib89","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nbt.1733","article-title":"Expression of therapeutic proteins after delivery of chemically modified mRNA in mice","volume":"29","author":"Kormann","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cellin.2022.100067_bib90","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.95918","article-title":"Functional correction of dystrophin actin binding domain mutations by genome editing","volume":"2","author":"Kyrychenko","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.cellin.2022.100067_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/v13081528","article-title":"Lentiviral vectors for T cell engineering: clinical applications, bioprocessing and future perspectives","volume":"13","author":"Labbe","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.cellin.2022.100067_bib93","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/embor.2011.46","article-title":"APOBEC3A can activate the DNA damage response and cause cell-cycle arrest","volume":"12","author":"Landry","year":"2011","journal-title":"EMBO Rep."},{"key":"10.1016\/j.cellin.2022.100067_bib94","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1126\/science.abb1390","article-title":"DNA capture by a CRISPR-Cas9-guided adenine base editor","volume":"369","author":"Lapinaite","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cellin.2022.100067_bib95","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nature25022","article-title":"From haematopoietic stem cells to complex differentiation landscapes","volume":"553","author":"Laurenti","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2022.100067_bib96","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.omtm.2016.12.006","article-title":"Global manufacturing of CAR T cell therapy","volume":"4","author":"Levine","year":"2017","journal-title":"Mol. Ther. Methods. Clin. Dev."},{"key":"10.1016\/j.cellin.2022.100067_bib97","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/s41587-019-0393-7","article-title":"Targeted, random mutagenesis of plant genes with dual cytosine and adenine base editors","volume":"38","author":"Li","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cellin.2022.100067_bib98","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1038\/s41467-022-29339-9","article-title":"Highly efficient prime editing by introducing same-sense mutations in pegRNA or stabilizing its structure","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellin.2022.100067_bib99","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.stem.2018.06.002","article-title":"Human iPSC-derived natural killer cells engineered with chimeric antigen receptors enhance anti-tumor activity","volume":"23","author":"Li","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.cellin.2022.100067_bib100","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev.biochem.052308.093131","article-title":"The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway","volume":"79","author":"Lieber","year":"2010","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.cellin.2022.100067_bib101","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nrm1202","article-title":"Mechanism and regulation of human non-homologous DNA end-joining","volume":"4","author":"Lieber","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cellin.2022.100067_bib102","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.04766","article-title":"Enhanced homology-directed human genome engineering by controlled timing of CRISPR\/Cas9 delivery","volume":"3","author":"Lin","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.cellin.2022.100067_bib103","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1161\/ATVBAHA.117.309962","article-title":"Differentiation, evaluation, and application of human induced pluripotent stem cell-derived endothelial cells","volume":"37","author":"Lin","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cellin.2022.100067_bib104","series-title":"ASH 2020 Annual Meeting","article-title":"Adenine base editing of gamma globin gene promoters shows no detectable off target RNA or DNA editing","author":"Ling","year":"2020"},{"key":"10.1016\/j.cellin.2022.100067_bib105","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1080\/10717544.2018.1474964","article-title":"Delivering CRISPR: a review of the challenges and approaches","volume":"25","author":"Lino","year":"2018","journal-title":"Drug Deliv."},{"issue":"9","key":"10.1016\/j.cellin.2022.100067_bib106","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/s41587-022-01255-9","article-title":"A split prime editor with untethered reverse transcriptase and circular RNA template","volume":"40","author":"Liu","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cellin.2022.100067_bib107","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/s41467-021-22295-w","article-title":"Improved prime editors enable pathogenic allele correction and cancer modelling in adult mice","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellin.2022.100067_bib108","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0092-8674(00)80110-5","article-title":"Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection","volume":"86","author":"Liu","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.cellin.2022.100067_bib109","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13045-020-01014-w","article-title":"NK cell-based cancer immunotherapy: from basic biology to clinical development","volume":"14","author":"Liu","year":"2021","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.cellin.2022.100067_bib173","author":"Liu"},{"key":"10.1016\/j.cellin.2022.100067_bib110","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/cr.2016.142","article-title":"CRISPR-Cas9-mediated multiplex gene editing in CAR-T cells","volume":"27","author":"Liu","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.cellin.2022.100067_bib111","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41591-020-0840-5","article-title":"Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer","volume":"26","author":"Lu","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellin.2022.100067_bib174","series-title":"PD-1 Knockout Engineered T Cells for Metastatic Non-small Cell Lung Cancer","author":"Lu","year":"2016"},{"key":"10.1016\/j.cellin.2022.100067_bib112","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.stemcr.2018.11.006","article-title":"Beta cell replacement after gene editing of a neonatal diabetes-causing mutation at the insulin locus","volume":"11","author":"Ma","year":"2018","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.cellin.2022.100067_bib113","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","article-title":"Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10","volume":"25","author":"Maeder","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellin.2022.100067_bib114","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41579-019-0299-x","article-title":"Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants","volume":"18","author":"Makarova","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.cellin.2022.100067_bib116","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1186\/s13287-021-02420-8","article-title":"Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients","volume":"12","author":"Marofi","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.cellin.2022.100067_bib117","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax9106","article-title":"Gene-edited human stem cell-derived beta cells from a patient with monogenic diabetes reverse preexisting diabetes in mice","volume":"12","author":"Maxwell","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cellin.2022.100067_bib118","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.3748\/wjg.v13.i47.6347","article-title":"Transplantation for the treatment of type 1 diabetes","volume":"13","author":"Meloche","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cellin.2022.100067_bib119","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1182\/bloodadvances.2019000820","article-title":"Genome editing of HBG1 and HBG2 to induce fetal hemoglobin","volume":"3","author":"Metais","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.cellin.2022.100067_bib120","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41587-020-0412-8","article-title":"Continuous evolution of SpCas9 variants compatible with non-G PAMs","volume":"38","author":"Miller","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cellin.2022.100067_bib224","author":"Miller"},{"key":"10.1016\/j.cellin.2022.100067_bib121","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav4324","article-title":"CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells","volume":"5","author":"Min","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.cellin.2022.100067_bib122","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2471\/BLT.06.036673","article-title":"Global epidemiology of haemoglobin disorders and derived service indicators","volume":"86","author":"Modell","year":"2008","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.cellin.2022.100067_bib123","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/323646a0","article-title":"Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene","volume":"323","author":"Monaco","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2022.100067_bib124","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s13238-018-0605-9","article-title":"In vitro transcribed sgRNA causes cell death by inducing interferon release","volume":"10","author":"Mu","year":"2019","journal-title":"Protein Cell"},{"key":"10.1016\/j.cellin.2022.100067_bib125","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1038\/s41418-020-00624-8","article-title":"Crosstalk between cGAS-STING signaling and cell death","volume":"27","author":"Murthy","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cellin.2022.100067_bib126","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJM199306103282306","article-title":"Long-term complications of diabetes mellitus","volume":"328","author":"Nathan","year":"1993","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cellin.2022.100067_bib127","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41587-021-01039-7","article-title":"Engineered pegRNAs improve prime editing efficiency","volume":"40","author":"Nelson","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cellin.2022.100067_bib128","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41586-021-03609-w","article-title":"Base editing of haematopoietic stem cells rescues sickle cell disease in mice","volume":"595","author":"Newby","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2022.100067_bib129","series-title":"Applied Base Editing to Treat Beta Hemoglobinopathies","author":"Nicole Gaudelli","year":"2021"},{"key":"10.1016\/j.cellin.2022.100067_bib130","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf8729","article-title":"Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems","volume":"353","author":"Nishida","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.cellin.2022.100067_bib131","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nature17664","article-title":"Efficient introduction of specific homozygous and heterozygous mutations using CRISPR\/Cas9","volume":"533","author":"Paquet","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2022.100067_bib132","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cellin.2022.100067_bib133","doi-asserted-by":"crossref","first-page":"7955","DOI":"10.1093\/nar\/gkz475","article-title":"Highly efficient editing of the \u03b2-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease","volume":"47","author":"Park","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cellin.2022.100067_bib134","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.omtn.2019.05.025","article-title":"In vivo outcome of homology-directed repair at the HBB gene in HSC using alternative donor template delivery methods","volume":"17","author":"Pattabhi","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.cellin.2022.100067_bib135","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/s41467-019-09614-y","article-title":"Gene correction for SCID-X1 in long-term hematopoietic stem cells","volume":"10","author":"Pavel-Dinu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellin.2022.100067_bib136","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41587-021-00901-y","article-title":"CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells","volume":"40","author":"Petri","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cellin.2022.100067_bib137","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1126\/science.1132998","article-title":"RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates","volume":"314","author":"Pichlmair","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.cellin.2022.100067_bib138","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.cellin.2022.100067_bib139","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cell.2014.09.014","article-title":"CRISPR-Cas9 knockin mice for genome editing and cancer modeling","volume":"159","author":"Platt","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.cellin.2022.100067_bib140","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/s41573-020-0084-6","article-title":"Base editing: advances and therapeutic opportunities","volume":"19","author":"Porto","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cellin.2022.100067_bib141","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162704","article-title":"Opportunistic infections in HIV-infected patients differ strongly in frequencies and spectra between patients with low CD4+ cell counts examined postmortem and compensated patients examined antemortem irrespective of the HAART era","volume":"11","author":"Powell","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cellin.2022.100067_bib142","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.cell.2015.02.029","article-title":"Codon optimality is a major determinant of mRNA stability","volume":"160","author":"Presnyak","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.cellin.2022.100067_bib143","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.cell.2013.02.011","article-title":"Chromatin remodeling at DNA double-strand breaks","volume":"152","author":"Price","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.cellin.2022.100067_bib144","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1038\/s41467-020-17626-2","article-title":"Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - aldrich Syndrome","volume":"11","author":"Rai","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellin.2022.100067_bib145","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature14299","article-title":"In vivo genome editing using Staphylococcus aureus Cas9","volume":"520","author":"Ran","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2022.100067_bib146","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","article-title":"Base editing: precision chemistry on the genome and transcriptome of living cells","volume":"19","author":"Rees","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.cellin.2022.100067_bib147","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1158\/1078-0432.CCR-16-1300","article-title":"Multiplex genome editing to generate universal CAR T cells resistant to PD1 inhibition","volume":"23","author":"Ren","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellin.2022.100067_bib148","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s41587-020-0453-z","article-title":"Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity","volume":"38","author":"Richter","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cellin.2022.100067_bib149","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-1-59745-194-9_2","article-title":"Mechanism by which electroporation mediates DNA migration and entry into cells and targeted tissues","volume":"423","author":"Rols","year":"2008","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.cellin.2022.100067_bib150","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.ymthe.2019.05.014","article-title":"Editing the sickle cell disease mutation in human hematopoietic stem cells: comparison of endonucleases and homologous donor templates","volume":"27","author":"Romero","year":"2019","journal-title":"Molecular Therapy"},{"key":"10.1016\/j.cellin.2022.100067_bib151","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-018-0326-5","article-title":"Reprogramming human T cell function and specificity with non-viral genome targeting","volume":"559","author":"Roth","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2022.100067_bib152","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.coi.2009.02.009","article-title":"The promise and potential pitfalls of chimeric antigen receptors","volume":"21","author":"Sadelain","year":"2009","journal-title":"Current Opinion in Immunology"},{"key":"10.1016\/j.cellin.2022.100067_bib153","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics--developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.cellin.2022.100067_bib154","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41587-020-0509-0","article-title":"Base editors for simultaneous introduction of C-to-T and A-to-G mutations","volume":"38","author":"Sakata","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cellin.2022.100067_bib155","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/382722a0","article-title":"Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene","volume":"382","author":"Samson","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2022.100067_bib156","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1126\/science.1165409","article-title":"Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A","volume":"322","author":"Sankaran","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.cellin.2022.100067_bib157","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.tem.2017.05.005","article-title":"A\u00a0unified pathophysiological construct of diabetes and its complications","volume":"28","author":"Schwartz","year":"2017","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.cellin.2022.100067_bib160","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1084\/jem.20171626","article-title":"Optimized RNP transfection for highly efficient CRISPR\/Cas9-mediated gene knockout in primary T cells","volume":"215","author":"Seki","year":"2018","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.cellin.2022.100067_bib161","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nrendo.2016.178","article-title":"Clinical pancreatic islet transplantation","volume":"13","author":"Shapiro","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cellin.2022.100067_bib162","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jaci.2013.09.044","article-title":"Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience","volume":"133","author":"Shearer","year":"2014","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.cellin.2022.100067_bib163","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.gene.2017.09.010","article-title":"CRISPR knock out CTLA-4 enhances the anti-tumor activity of cytotoxic T lymphocytes","volume":"636","author":"Shi","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.cellin.2022.100067_bib164","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.molcel.2015.10.008","article-title":"Discovery and functional characterization of diverse class 2 CRISPR-cas systems","volume":"60","author":"Shmakov","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cellin.2022.100067_bib165","article-title":"High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails","author":"Shy","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cellin.2022.100067_bib166","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41409-019-0624-z","article-title":"Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors","volume":"55","author":"Styczynski","year":"2020","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.cellin.2022.100067_bib167","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.cellin.2022.100067_bib168","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.cellin.2022.100067_bib169","doi-asserted-by":"crossref","first-page":"865","DOI":"10.4065\/73.9.865","article-title":"Primary immunodeficiencies","volume":"73","author":"Ten","year":"1998","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.cellin.2022.100067_bib170","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nm.4170","article-title":"A\u00a0genome-editing strategy to treat beta-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition","volume":"22","author":"Traxler","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellin.2022.100067_bib176","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1172\/JCI129204","article-title":"Immune escape and immunotherapy of acute myeloid leukemia","volume":"130","author":"Vago","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.cellin.2022.100067_bib177","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.omtn.2018.06.010","article-title":"Uridine depletion and chemical modification increase Cas9 mRNA activity and reduce immunogenicity without HPLC purification","volume":"12","author":"Vaidyanathan","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.cellin.2022.100067_bib219","author":"Vertex Pharmaceuticals Incorporated"},{"key":"10.1016\/j.cellin.2022.100067_bib220","author":"Vertex Pharmaceuticals Incorporated"},{"key":"10.1016\/j.cellin.2022.100067_bib221","author":"Vertex Pharmaceuticals Incorporated"},{"key":"10.1016\/j.cellin.2022.100067_bib222","author":"Vertex Pharmaceuticals Incorporated"},{"key":"10.1016\/j.cellin.2022.100067_bib223","author":"Vertex Pharmaceuticals Incorporated"},{"key":"10.1016\/j.cellin.2022.100067_bib178","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/hum.2014.2525","article-title":"Vector integration and tumorigenesis","volume":"25","author":"von Kalle","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.cellin.2022.100067_bib211","author":"Vor Biopharma"},{"key":"10.1016\/j.cellin.2022.100067_bib225","author":"Walters"},{"key":"10.1016\/j.cellin.2022.100067_bib179","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1126\/science.aba8853","article-title":"Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants","volume":"368","author":"Walton","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cellin.2022.100067_bib180","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41592-022-01399-1","article-title":"Efficient targeted insertion of large DNA fragments without DNA donors","volume":"19","author":"Wang","year":"2022","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cellin.2022.100067_bib181","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41422-019-0267-z","article-title":"Reactivation of gamma-globin expression through Cas9 or base editor to treat beta-hemoglobinopathies","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.cellin.2022.100067_bib182","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41556-021-00671-4","article-title":"Eliminating base-editor-induced genome-wide and transcriptome-wide off-target mutations","volume":"23","author":"Wang","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cellin.2022.100067_bib172","author":"Wang"},{"key":"10.1016\/j.cellin.2022.100067_bib183","doi-asserted-by":"crossref","DOI":"10.1038\/mto.2016.15","article-title":"Clinical manufacturing of CAR T cells: foundation of a promising therapy","volume":"3","author":"Wang","year":"2016","journal-title":"Mol Ther Oncolytics"},{"key":"10.1016\/j.cellin.2022.100067_bib184","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41588-018-0094-z","article-title":"Switching from fetal to adult hemoglobin","volume":"50","author":"Wang","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cellin.2022.100067_bib185","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/35066048","article-title":"Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias","volume":"2","author":"Weatherall","year":"2001","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.cellin.2022.100067_bib186","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay9392","article-title":"Editing a gamma-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype","volume":"6","author":"Weber","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.cellin.2022.100067_bib187","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1126\/science.8493571","article-title":"How does HIV cause AIDS?","volume":"260","author":"Weiss","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.cellin.2022.100067_bib188","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1182\/blood-2010-11-316893","article-title":"Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities","volume":"117","author":"Wilber","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cellin.2022.100067_bib189","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1586\/1744666X.2015.1062366","article-title":"Current and emerging treatment options for Wiskott-Aldrich syndrome","volume":"11","author":"Worth","year":"2015","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.cellin.2022.100067_bib60","author":"Wu"},{"key":"10.1016\/j.cellin.2022.100067_bib190","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41591-019-0401-y","article-title":"Highly efficient therapeutic gene editing of human hematopoietic stem cells","volume":"25","author":"Wu","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellin.2022.100067_bib191","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102975","article-title":"CAR-NK cells: a promising cellular immunotherapy for cancer","volume":"59","author":"Xie","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cellin.2022.100067_bib192","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1056\/NEJMoa1817426","article-title":"CRISPR-edited stem cells in a patient with HIV and acute lymphocytic leukemia","volume":"381","author":"Xu","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cellin.2022.100067_bib193","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.ymthe.2017.04.027","article-title":"CRISPR\/Cas9-Mediated CCR5 ablation in human hematopoietic stem\/progenitor cells confers HIV-1 resistance in vivo","volume":"25","author":"Xu","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cellin.2022.100067_bib194","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.stem.2012.05.005","article-title":"Induced pluripotent stem cells: past, present, and future","volume":"10","author":"Yamanaka","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.cellin.2022.100067_bib195","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.stem.2020.09.014","article-title":"Pluripotent stem cell-based cell therapy-promise and challenges","volume":"27","author":"Yamanaka","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.cellin.2022.100067_bib217","author":"Yang"},{"key":"10.1016\/j.cellin.2022.100067_bib197","series-title":"Enhancing Prime Editing Efficiency and Flexibility with Tethered and Split pegRNAs","author":"Ying Feng","year":"2022"},{"key":"10.1016\/j.cellin.2022.100067_bib198","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.cellin.2022.100067_bib199","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.molcel.2018.09.002","article-title":"Genetic modulation of RNA splicing with a CRISPR-guided cytidine deaminase","volume":"72","author":"Yuan","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cellin.2022.100067_bib200","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41591-020-0790-y","article-title":"Therapeutic base editing of human hematopoietic stem cells","volume":"26","author":"Zeng","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellin.2022.100067_bib201","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","article-title":"Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system","volume":"163","author":"Zetsche","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.cellin.2022.100067_bib202","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41586-022-05140-y","article-title":"Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL","volume":"609","author":"Zhang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2022.100067_bib203","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1038\/s41467-021-24017-8","article-title":"AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellin.2022.100067_bib204","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00280-019-03800-x","article-title":"Disruption of CTLA-4 expression on peripheral blood CD8 + T cell enhances anti-tumor efficacy in bladder cancer","volume":"83","author":"Zhang","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.cellin.2022.100067_bib205","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41556-020-0518-8","article-title":"Increasing the efficiency and targeting range of cytidine base editors through fusion of a single-stranded DNA-binding protein domain","volume":"22","author":"Zhang","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cellin.2022.100067_bib206","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/s41587-020-0527-y","article-title":"Dual base editor catalyzes both cytosine and adenine base conversions in human cells","volume":"38","author":"Zhang","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cellin.2022.100067_bib213","author":"Zhang"},{"key":"10.1016\/j.cellin.2022.100067_bib207","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1602814","article-title":"CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice","volume":"3","author":"Zhang","year":"2017","journal-title":"Sci. Adv."},{"key":"10.1016\/j.cellin.2022.100067_bib208","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell. Mol. Immunol."}],"updated-by":[{"DOI":"10.1016\/j.cellin.2024.100225","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000}}],"container-title":["Cell Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772892722000645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772892722000645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T13:25:21Z","timestamp":1757424321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772892722000645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":205,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2772892722000645"],"URL":"https:\/\/doi.org\/10.1016\/j.cellin.2022.100067","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.cellin.2024.100225","asserted-by":"object"}]},"ISSN":["2772-8927"],"issn-type":[{"value":"2772-8927","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current advances of CRISPR-Cas technology in cell therapy","name":"articletitle","label":"Article Title"},{"value":"Cell Insight","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellin.2022.100067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V. on behalf of Wuhan University.","name":"copyright","label":"Copyright"}],"article-number":"100067"}}